These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10438065)

  • 1. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
    Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS
    Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC; Yeh MK; Coombes AG; Davis SS
    Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.
    Coombes AG; Lavelle EC; Jenkins PG; Davis SS
    Vaccine; 1996 Oct; 14(15):1429-38. PubMed ID: 8994318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.
    Takahata H; Lavelle EC; Coombes AG; Davis SS
    J Control Release; 1998 Jan; 50(1-3):237-46. PubMed ID: 9685890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
    Rajkannan R; Dhanaraju MD; Gopinath D; Selvaraj D; Jayakumar R
    Vaccine; 2006 Jun; 24(24):5149-57. PubMed ID: 16713035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
    Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
    Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
    O'Hagan DT; Jeffery H; Davis SS
    Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.
    Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ
    Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice.
    Chattaraj SC; Rathinavelu A; Das SK
    J Control Release; 1999 Mar; 58(2):223-32. PubMed ID: 10053195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination.
    Yeh M; Chiang C
    J Microencapsul; 2004 Feb; 21(1):91-106. PubMed ID: 14718189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine.
    Sturesson C; Degling Wikingsson L
    J Control Release; 2000 Sep; 68(3):441-50. PubMed ID: 10974398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers.
    Yeh MK; Davis SS; Coombes AG
    Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres.
    Allaoui-Attarki K; Fattal E; Pecquet S; Trollé S; Chachaty E; Couvreur P; Andremont A
    Vaccine; 1998 Apr; 16(7):685-91. PubMed ID: 9562687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.
    Singh M; Carlson JR; Briones M; Ugozzoli M; Kazzaz J; Barackman J; Ott G; O'Hagan D
    Vaccine; 1998 Nov; 16(19):1822-7. PubMed ID: 9795387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
    Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles.
    Yeh MK; Liu YT; Chen JL; Chiang CH
    J Control Release; 2002 Aug; 82(2-3):237-47. PubMed ID: 12175740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.